Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide for Endothelial Dysfunction in Chronic Venous Insufficiency After Surgery
NCT04180137Completed
- Start
- Nov 2019
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sulodexide in chronic venous insufficiency (CVI) (2 arms). Primary endpoint: Changes in circulating endothelial cells at 32 days. Started Nov 2019; status: completed.
02
Drugs
sulodexide
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT04180137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04180137.